News

The researchers looked at human nuclear DNA for mutations using the Mapping 100K Set; they used the Human Mitochondrial Resequencing Array 2.0 to look for mutations in mitochondrial DNA.

With the integration of ChemAxon's JChem Cartridge for Oracle and Marvin toolkits, eNovator is able to store, edit, search and retrieve chemical structures and reactions within the ELN and Sample Tracking Module.

The companies demonstrated their first joint product, a software module that is designed to allow scientists to use ChemDraw® to search by chemical structure for all of the compounds in the existing Adis R&D Insight® database.

WellGen uses its patented screening technology to screen naturally occurring compounds, which are generally regarded as safe, against a panel of genes associated with wellness and disease.

Patent discloses how to use acoustics to monitor the composition and volume of a fluid and maintain those parameters via active fluid supplementation.

Argenta will apply its integrated medicinal chemistry, assay development and screening capabilities and collaborate with Cellzome's scientists.

Key Organics will provide compounds for screening against druggable targets using RBC's DiscoveryDot™ screening technology.

European Commission has awarded Deerac Fluidics under the FP6 Marie Curie Host Fellowships for Transfer of Knowledge program a contract to develop additional low volume liquid handling technology.

SpliceArrays’ design allows the detection of both the reference and alternatively spliced forms of targeted genes on Agilent’s microarray platform.

This licence allows the NMC to extend its microarray sales into European territories covered by the OGT Southern array patents.